Dr. Rachel Miller, M.D.
Claim this profileUniversity of Kentucky
Studies Cancer
Studies Ovarian Cancer
7 reported clinical trials
16 drugs studied
Area of expertise
1Cancer
Stage IV
BRCA1 negative
BRCA2 negative
2Ovarian Cancer
AKT positive
BRCA1 positive
PI3K positive
Affiliated Hospitals
Clinical Trials Rachel Miller, M.D. is currently running
Mirvetuximab + Bevacizumab
for Ovarian Cancer
GLORIOSA is a Phase 3 multicenter, open label study designed to evaluate the safety and efficacy of mirvetuximab Soravtansine + Bevacizumab as maintenance therapy in participants with platinum-sensitive ovarian, primary peritoneal or fallopian tube cancers with high folate receptor-alpha (FRα) expression.
Recruiting2 awards Phase 3
Nodal Sampling
for Endometrial Cancer
This study aims to estimate the recurrence-free survival rates in women with endometrial cancer treated with selective versus sentinel node surgical staging. This study will gather information to help determine the best way to evaluate lymph nodes during surgery for endometrial cancer.
Recruiting1 award N/A3 criteria
More about Rachel Miller, M.D.
Clinical Trial Related2 years of experience running clinical trials · Led 7 trials as a Principal Investigator · 5 Active Clinical TrialsTreatments Rachel Miller, M.D. has experience with
- Paclitaxel
- Therapeutic Intervention
- REFLEX
- Selective Surgical Staging
- Afuresertib
- Bevacizumab
Breakdown of trials Rachel Miller, M.D. has run
Cancer
Ovarian Cancer
Endometrial Cancer
Fallopian Tube Cancer
Peritoneal Neoplasm
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Rachel Miller, M.D. specialize in?
Rachel Miller, M.D. focuses on Cancer and Ovarian Cancer. In particular, much of their work with Cancer has involved Stage IV patients, or patients who are BRCA1 negative.
Is Rachel Miller, M.D. currently recruiting for clinical trials?
Yes, Rachel Miller, M.D. is currently recruiting for 5 clinical trials in Lexington Kentucky. If you're interested in participating, you should apply.
Are there any treatments that Rachel Miller, M.D. has studied deeply?
Yes, Rachel Miller, M.D. has studied treatments such as Paclitaxel, Therapeutic Intervention, REFLEX.
What is the best way to schedule an appointment with Rachel Miller, M.D.?
Apply for one of the trials that Rachel Miller, M.D. is conducting.
What is the office address of Rachel Miller, M.D.?
The office of Rachel Miller, M.D. is located at: University of Kentucky, Lexington, Kentucky 40536 United States. This is the address for their practice at the University of Kentucky.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.